World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
12799
World Ranking
4036
National Ranking
159

Marij J. P. Welters publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marij J. P. Welters sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 173 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marij J. P. Welters D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marij J. P. Welters sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 52 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marij J. P. Welters is affiliated with the Leiden University Medical Center in the Netherlands. Their research predominantly spans the fields of medicine and immunology and microbiology, with a particular focus on oncology and immunology. Their work engages with various subfields including epidemiology, molecular biology, and obstetrics and gynecology.

The core topics of Welters' research include cancer immunotherapy and biomarkers, immunotherapy and immune responses, CAR-T cell therapy research, cervical cancer and HPV research, immune cell function and interaction, endometrial and cervical cancer treatments, as well as single-cell and spatial transcriptomics.

Frequent publication venues for their research include:

  • Journal for ImmunoTherapy of Cancer
  • Nature Communications
  • Cancer Immunology Research
  • Cancers
  • Cancer Immunology Immunotherapy

Welters has collaborated extensively with several coauthors such as Sjoerd H. van der Burg, Saskia J. Santegoets, Mariëtte I.E. van Poelgeest, Judith R. Kroep, and Els M.E. Verdegaal.

Among their recent publications are the following papers:

  • Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial, 2020, Nature Communications
  • CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer, 2020, Cancer Immunology Research
  • Strong vaccine responses during chemotherapy are associated with prolonged cancer survival, 2020, Science Translational Medicine
  • Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment, 2023, Nature Communications
  • CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors, 2024, Cellular and Molecular Immunology

Best Publications

  • Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

    Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik

  • Actively personalized vaccination trial for newly diagnosed glioblastoma

    Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur

  • Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.

    Marij J P Welters;Gemma G Kenter;Sytse J Piersma;Annelies P G Vloon

  • Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity

    Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik

  • Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.

    Pia Kvistborg;Daisy Philips;Sander Kelderman;Lois Hageman

  • Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment

    Eveline M. Dijkgraaf;Moniek Heusinkveld;Bart Tummers;Lisa T.C. Vogelpoel

  • M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.

    Moniek Heusinkveld;Peggy J. de Vos van Steenwijk;Renske Goedemans;Tamara H. Ramwadhdoebe

  • Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

    Marij J. P. Welters;Gemma G. Kenter;Peggy J. de Vos van Steenwijk;Margriet J. G. Löwik

  • NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.

    Nadine van Montfoort;Linda Borst;Michael J. Korrer;Marjolein Sluijter

  • Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.

    Marij J. P. Welters;Annemieke de Jong;Susan J. F. van den Eeden;Jeanette M. van der Hulst

  • Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens

    Sjoerd H. van der Burg;Sytse J. Piersma;Annemieke de Jong;Jeanette M. van der Hulst

  • Response definition criteria for ELISPOT assays revisited.

    Z. Moodie;L. Price;C. Gouttefangeas;A Mander

  • Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer.

    Frank M. Speetjens;Peter J.K. Kuppen;Marij J.P. Welters;Farah Essahsah

  • HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

    Mariette I E van Poelgeest;Marij J P Welters;Edith M G van Esch;Linda F M Stynenbosch

  • Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

    Susanna Mandruzzato;Sven Brandau;Cedrik M. Britten;Cedrik M. Britten;Vincenzo Bronte

  • Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.

    Marij J. Welters;Tetje C. van der Sluis;Hélène van Meir;Nikki M. Loof

  • Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.

    Saskia J. A. M. Santegoets;Eveline M. Dijkgraaf;Alessandra Battaglia;Philipp Beckhove

  • A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer

    E. M. Dijkgraaf;S. J. A. M. Santegoets;An Reyners;R. Goedemans

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

    Mariëtte I E van Poelgeest;Marij J P Welters;Renee Vermeij;Linda F M Stynenbosch

  • The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.

    C. M. Britten;C. Gouttefangeas;M. J. P. Welters;G. Pawelec

Frequent Co-Authors

Sjoerd H. van der Burg
Sjoerd H. van der Burg Leiden University Medical Center
Cornelis J. M. Melief
Cornelis J. M. Melief ISA Pharmaceuticals (Netherlands)
Gemma G. Kenter
Gemma G. Kenter Vrije Universiteit Amsterdam
Gert Jan Fleuren
Gert Jan Fleuren Leiden University Medical Center
Christian H. Ottensmeier
Christian H. Ottensmeier University of Southampton
Rienk Offringa
Rienk Offringa German Cancer Research Center
Jan W. Drijfhout
Jan W. Drijfhout Leiden University Medical Center
Ekaterina S. Jordanova
Ekaterina S. Jordanova Vrije Universiteit Amsterdam
Kees L. M. C. Franken
Kees L. M. C. Franken Leiden University Medical Center
Per thor Straten
Per thor Straten University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields can broaden career options. Many professionals choose to enhance their expertise through nursing degrees that complement immunological knowledge. Online programs offer flexible pathways, allowing students to advance while balancing other commitments.

The accelerated nurse practitioner program is an excellent option for those aiming to take on advanced clinical roles quickly. These programs focus on developing specialized skills in patient care, often integrating immunological concepts relevant to disease prevention and treatment.

For individuals without a nursing background, online accelerated nursing programs for non nurses provide a fast track into the nursing profession. These programs are designed to build foundational clinical knowledge alongside scientific principles relevant to immunology.

Finding the right program is crucial, and many students look for options that fit their schedule and entry requirements. Resources that highlight accelerated nursing programs near me can simplify the search for feasible education paths.

Lastly, those seeking entry-level healthcare roles might consider easy lpn programs to get into. Licensed practical nurse programs offer practical experience and can serve as a stepping stone toward more advanced immunology or nursing degrees.

Best Scientists Citing Marij J. P. Welters

Trending Scientists

Recently Published Articles